{
  "api": "assay-systems/v1",
  "key_tier": "none",
  "retrieved": "2026-10-16T17:36:08Z",
  "source": "Assay Systems register, https://assay-systems.com/register/",
  "access_notice": "On 15 November 2026, automated access to assay-systems.com closes. After that date, access is available only under a paid annual subscription contract. Contact: contact@assay-systems.com",
  "data": {
    "id": "ASY-CA-02W0HD30TJ",
    "type": "grant",
    "country": "ca",
    "name": "Coalition for Epidemic Preparedness: federal grants and contributions",
    "url": "https://assay-systems.com/register/ca/grants/r/coalition-for-epidemic-preparedness/",
    "summary": "5 federal grant and contribution agreements worth $214M with Coalition for Epidemic Preparedness, 2017–2023.",
    "figures": [
      {
        "label": "agreements",
        "value": 5,
        "unit": "count"
      },
      {
        "label": "value",
        "value": 214000000,
        "unit": "money",
        "currency": "CAD",
        "approximate": true,
        "display": "$214M"
      },
      {
        "label": "departments",
        "value": 1,
        "unit": "count"
      },
      {
        "label": "programs",
        "value": 3,
        "unit": "count"
      }
    ],
    "text": [
      "This grant represents Canada’s long-term institutional support to the Coalition for Epidemic Preparedness Innovations (CEPI). CEPI uses these funds, along with other donors’ funding, to achieve its mandate. CEPI’s mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. This project supports CEPI’s 2022 to 2026 strategy (CEPI 2.0), which has three strategic objectives: (1) preparing for known epidemic and pandemic threats; (2) transforming future responses to novel infectious",
      "P009527001, P009527002 & P009527003: Canada support to CEPI is intended to address the COVID-19 challenge faced by developing countries. With already weak health systems and limited diagnostic capabilities, developing countries are particularly at risk of the outbreak spreading, potentially bearing a disproportionate share of the cost of the outbreak in terms of human suffering and economic impact. In addition, the disease and necessary containment measures will disproportionately harm the poor and other vulnerable groups in developing countries. This is further exacerbated by existing epidemi",
      "Payments to other international organizations",
      "This project aims to o accelerate the development of vaccines against prominent epidemic and pandemic threat pathogens and ensure equitable access for affected population during outbreaks."
    ],
    "records": [
      {
        "name": "grants and contributions register",
        "url": "https://assay-systems.com/register/ca/grants/"
      },
      {
        "name": "Global Affairs Canada",
        "url": "https://assay-systems.com/register/ca/grants/department/global-affairs-canada/"
      }
    ],
    "assay_record": "ASY-CA-02W0HD30TJ",
    "cite_as": "Assay Systems, \"Coalition for Epidemic Preparedness: federal grants and contributions\", https://assay-systems.com/register/ca/grants/r/coalition-for-epidemic-preparedness/"
  }
}